Incyte
INCY
#980
Rank
NZ$43.69 B
Marketcap
NZ$214.36
Share price
0.51%
Change (1 day)
13.81%
Change (1 year)

Incyte (INCY) - Total liabilities

Total liabilities on the balance sheet as of September 2026 : NZ$2.93 Billion

According to Incyte's latest financial reports the company's total liabilities are NZ$2.93 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Incyte - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$2.51 B8.68%
2022-12-31NZ$2.31 B36.02%
2021-12-31NZ$1.70 B29.41%
2020-12-31NZ$1.31 B7.01%
2019-12-31NZ$1.22 B14.62%
2018-12-31NZ$1.07 B13.42%
2017-12-31NZ$0.94 B-46.24%
2016-12-31NZ$1.75 B44.04%
2015-12-31NZ$1.22 B9.03%
2014-12-31NZ$1.12 B11.95%
2013-12-31NZ$1.00 B62.96%
2012-12-31NZ$0.61 B-13.77%
2011-12-31NZ$0.71 B-4.94%
2010-12-31NZ$0.74 B-33.19%
2009-12-31NZ$1.12 B43.66%
2008-12-31NZ$0.78 B37.43%
2007-12-31NZ$0.56 B-8.72%
2006-12-31NZ$0.62 B8.12%
2005-12-31NZ$0.57 B-6.29%
2004-12-31NZ$0.61 B77.34%
2003-12-31NZ$0.34 B-27.39%
2002-12-31NZ$0.47 B-25.33%
2001-12-31NZ$0.63 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
NZ$141.86 B 4,739.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$206.12 B 6,932.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$192.15 B 6,455.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$149.64 B 5,005.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$2.17 B-25.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ$0.53 B-81.73%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ$0.24 B-91.63%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
NZ$0.12 B-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.76 B-74.04%๐Ÿ‡บ๐Ÿ‡ธ USA